These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10628321)

  • 61. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
    Kurose K; Zhou XP; Araki T; Eng C
    Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10.
    Poetsch M; Lorenz G; Kleist B
    Cancer Genet Cytogenet; 2002 Jan; 132(1):20-4. PubMed ID: 11801303
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Loss and inactivation of PTEN/MMAC1/TEP1 gene in lung cancer].
    Zhang L; Liu T; Liu H; Gao J; Gu C
    Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):85-8. PubMed ID: 11866895
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is exon 5 of the PTEN/MMAC1 gene a prognostic marker in anaplastic glioma?
    Rustia A; Wierzbicki V; Marrocco L; Tossini A; Zamponi C; Lista F
    Neurosurg Rev; 2001 Jul; 24(2-3):97-102. PubMed ID: 11485247
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.
    Kulke MH; Odze RD; Thakore KS; Thomas G; Wang H; Loda M; Eng C
    Br J Cancer; 2001 Mar; 84(6):748-53. PubMed ID: 11259087
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular genetic analysis of non-astrocytic gliomas.
    Tong CY; Ng HK; Pang JC; Hui AB; Ko HC; Lee JC
    Histopathology; 1999 Apr; 34(4):331-41. PubMed ID: 10231401
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors.
    Simpkins SB; Peiffer-Schneider S; Mutch DG; Gersell D; Goodfellow PJ
    Gynecol Oncol; 1998 Dec; 71(3):391-5. PubMed ID: 9887237
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers.
    Yaginuma Y; Yamashita T; Ishiya T; Morizaki A; Katoh Y; Takahashi T; Hayashi H; Ishikawa M
    Mol Carcinog; 2000 Feb; 27(2):110-6. PubMed ID: 10657903
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PTEN/MMAC1 in malignant melanoma and its importance for tumor progression.
    Poetsch M; Dittberner T; Woenckhaus C
    Cancer Genet Cytogenet; 2001 Feb; 125(1):21-6. PubMed ID: 11297763
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN.
    Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
    Blood; 2000 May; 95(9):2937-42. PubMed ID: 10779442
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma.
    Shao X; Tandon R; Samara G; Kanki H; Yano H; Close LG; Parsons R; Sato T
    Int J Cancer; 1998 Aug; 77(5):684-8. PubMed ID: 9688299
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
    Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
    Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM
    Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL).
    Leupin N; Cenni B; Novak U; Hügli B; Graber HU; Tobler A; Fey MF
    Br J Haematol; 2003 Apr; 121(1):97-100. PubMed ID: 12670337
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma.
    Nakahara Y; Nagai H; Kinoshita T; Uchida T; Hatano S; Murate T; Saito H
    Leukemia; 1998 Aug; 12(8):1277-80. PubMed ID: 9697884
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders.
    Aggerholm A; Grønbaek K; Guldberg P; Hokland P
    Eur J Haematol; 2000 Aug; 65(2):109-13. PubMed ID: 10966170
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract.
    Chang JG; Chen YJ; Perng LI; Wang NM; Kao MC; Yang TY; Chang CP; Tsai CH
    Eur J Cancer; 1999 Apr; 35(4):647-51. PubMed ID: 10492641
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lack of deletions of the PTEN/MMAC1 and MXI1 loci in renal cell carcinoma by interphase cytogenetics.
    Gesk S; Siebert R; Wacker HH; Nürnberg N; Harder L; Lehman J; Klöppel G; Grote W; Stöckle M; Schlegelberger B
    Cancer Genet Cytogenet; 2000 Apr; 118(1):87-8. PubMed ID: 10766523
    [No Abstract]   [Full Text] [Related]  

  • 80. [Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
    Li JY; Cao RF; Wang H; Xie QX; Wang GX; Xiong LS; Miao YR
    Ai Zheng; 2003 Jun; 22(6):607-11. PubMed ID: 12948410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.